Kyowa Hakko Bio Co., Ltd.

Kansai Paint Company, Ltd.

Meiji Dairies Corporation

Meiji Co., Ltd.

Miho Komatsu

Koji Morishita

Masato Saito

Shin-ichi Hashimoto

Toshikazu Kamiya

Masahiro Omura

Takahiro Hara

Masahiko Morita

Masayuki Ochiai

Hiroshi Tsuchita

Miho Takada

Goro Hori

Yoichiro Sugimura

Akemi Ogawa

Takeshi Shibasaki

Itaru Toda

A coating composition includes a binder component (A), a flake-like aluminum pigment (B) having an average particle diameter (d50) of 18 μm to 25 μm, and a flake-like pigment (C) being a flake-like pigment other than flake-like aluminum pigments and having an average particle diameter (d50) of 8 μm to 30 μm. A content of the flake-like aluminum pigment (B) is 10 parts by mass to 50 parts by mass and a content of the flake-like pigment (C) is 0.5 parts by mass to 10 parts by mass, based on 100 parts by mass of the binder component (A). A content ratio (B)/(C) of the flake-like aluminum pigment (B) to the flake-like pigment (C) is 2/1 to 50/1 in terms of a solid content mass ratio.

Coating composition, coated article and method for forming multilayer coating film

The present invention relates to a method of enhancing endurance of a human subject through administration of alanyl-glutamine or alanyl-glutamine salt. The invention includes unexpected discovery of alanyl-glutamine or alanyl-glutamine salt enhancing durability and endurance of human subject independent of an increase in the blood glutamine level.

Method to enhance endurance

An agent for enhancing NO production, comprising citrulline or a salt thereof and serine or a salt thereof as an active ingredient. An agent for preventing or ameliorating vascular endothelial malfunction, comprising citrulline or a salt thereof and serine or a salt thereof as an active ingredient. An agent for preventing or ameliorating a symptom caused by vascular endothelial malfunction, comprising citrulline or a salt thereof and serine or a salt thereof as an active ingredient.

Agent for preventing deterioration in vascular endothelial function or improving vascular endothelial function

A muscle fatigue remedy that for persons with the symptoms of muscle pain attributed to strenuous exercise, lassitude in the arms and legs attributed to acute exercise, lower back pain and stiffness in the shoulder attributed to taking of a certain posture over a prolonged period of time, etc., relieves the symptoms and allows them to have a fulfilling life. There is provided a muscle fatigue remedy containing alanylglutamine or its salt as an active ingredient.

Muscle fatigue remedy

A long-acting improver of muscular fatigue characterized by comprising 4 kinds of amino acids made up of leucine, isoleucine, valine and glutamine, and a whey protein component (whey protein and/or decomposition product of whey protein). At least one of a whey protein isolate (WPI), a whey protein concentrate (WPC), &#x3b2;-lactoglobulin, and &#x3b1;-lactalbumin is used as the whey protein. Novel food or drink, and pharmaceuticals which exhibit sustained recovery effects on muscular fatigue are provided.

Sustained improver of muscular fatigue

There has been a demand in the marketplace for medicines, functional foods and so on which can relieve subjective symptoms of fatigue in persons having these subjective symptoms, and enabling the persons to have productive days. That is, an object of the present invention is to provide a composition for relieving subjective symptoms of fatigue. According to the present invention, a safe and effective composition for relieving subjective symptoms of fatigue which contains ornithine or a salt thereof as an active ingredient can be provided.

Composition for relieving subjective symptoms of fatigue

Growing community of inventors

Tsukuba, Japan

Miho Komatsu